跳至主要内容
临床试验/EUCTR2005-005046-39-IT
EUCTR2005-005046-39-IT进行中(未招募)不适用

A randomized phase II study to assess the activity and tolerability of two regimens of metronomic oral chemotherapy methotrexate plus cyclophosphamide and cyclophosphamide plus capecitabine combined with bevacizumab in advanced breast cancer - ND

ISTITUTO EUROPEO DI ONCOLOGIA0 个研究点目标入组 92 人开始时间: 2006年1月31日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Pre- or post-menopausal women with histologically proven, locally advanced inoperable or metastatic breast carcinoma. Measurable disease, defined as at least one lesion that can be accurately measured No more than 3 previous lines of chemotherapy for advanced disease.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Presence of cerebral or leptomeningeal involvement. Previous or concomitant other malignancy except basal or squamous cell carcinoma of the skin or adequately treated in situ carcinoma of the cervix. History of allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab or other agents used in the study.

研究者

相似试验

进行中(未招募)
不适用
Randomized phase II trial evaluating the activity and the tolerability of fixed dose of oxycodone and increasing dose of pregabalin versus increasing dose of oxycodone and fixed dose of pregabalin - NDpatients affected with cancer and presenting a neuropatic component in their painMedDRA version: 9.1Level: SOCClassification code 10029205Term: Nervous system disorders
EUCTR2007-005222-69-ITAssociazione Progetto Oncologia UMAN.A
进行中(未招募)
不适用
A phase II randomised study to investigate the effects of Bevacizumab on cell proliferation and on pCR in patients with locally advanced operable breast cancer - ND
EUCTR2005-005048-19-ITISTITUTO EUROPEO DI ONCOLOGIA120
尚未招募
2 期
A randomised phase 2 study of carboplatin with oral vinorelbine followed by maintenance therapy with oral vinorelbine or erlotinib in elderly patients with metastatic non-small cell lung cancer.on Small Cell Lung CancerNon Small Cell Lung CancerCancer - Lung - Non small cell
ACTRN12612000473864Southern Health100
招募中
2 期
A randomised phase II study to evaluate the effectiveness of botulinum toxin to delay, and possibly prevent, progressive foot deformities in children with Charcot-Marie-Tooth (CMT) disease.Charcot-Marie-Tooth diseaseHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disorders
ACTRN12605000115639The Children's Hospital at Westmead10
招募中
1 期
Effects of natural seaweed extract (GFS) on mobilisation of human bone marrow stem cells and immune system activatioormal volunteersNormal volunteersOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveInflammatory and Immune System - Normal development and function of the immune system
ACTRN12605000021673Tas100
A randomized phase II study to assess the activity... | 临床试验